Home / Anti-infectives / Ribavirin
ATC J05AP01 · Antivirals for treatment of HCV infections
Ribavirin shortage
As of 2 Nov 2026, Ribavirin has a reported shortage in 1 of the 16 countries we track (Japan), covering 1 product from 1 company.
Countries1/16
Products1packs or presentations
Companies11 listed
Short since2 Mar 20268 months ago
Earliest returnnot givencompany estimate
Main reasonOther
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan1 product shortNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
Japan
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Merck & Co. (MSD) MRK · NYSE
Compared with similar medicines
ATC group J05AP · Antivirals for treatment of HCV infectionsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | レベトールカプセル200mg | MSD | 2 Mar 2026 | not given | Other |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.